BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4713306)

  • 21. [Use in psychiatry of antiparkinson drugs].
    Bourgeois M; Mazaux JM; Imbert D; Daubech MJ; Daulouède JP; Tignol J
    Ann Med Psychol (Paris); 1976 Oct; 2(3):499-510. PubMed ID: 1020859
    [No Abstract]   [Full Text] [Related]  

  • 22. Benztropine psychosis.
    Ananth JV; Jain RC
    Can Psychiatr Assoc J; 1973 Oct; 18(5):409-14. PubMed ID: 4746144
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of extrapyramidal side effects induced by neuroleptics.
    Tune LE; McHugh PR; Coyle JT
    Johns Hopkins Med J; 1981 Mar; 148(3):149-53. PubMed ID: 7206408
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of the effect of certain pharmacological agents on tardive dyskinesias and the rabbit syndrome].
    Jus K; Jus A; Gautier J; Villeneuve A; Pires P; Pineau R; Villeneuve R
    Vie Med Can Fr; 1973 Sep; 2(9):871-5. PubMed ID: 4761483
    [No Abstract]   [Full Text] [Related]  

  • 25. Patterns of psychotropic drug use for schizophrenia.
    Laska E; Varga E; Wanderling J; Simpson G; Logemann GW; Shah BK
    Dis Nerv Syst; 1973; 34(6):294-305. PubMed ID: 4782286
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical trial of tropatepine chlorhydrate as a corrector of syndromes due to neuroleptics].
    Delaunay J; Guibert S
    Ann Med Psychol (Paris); 1976 Jan; 1(1):144-7. PubMed ID: 970819
    [No Abstract]   [Full Text] [Related]  

  • 27. Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtyping.
    Singh MM; Kay SR; Opler LA
    Psychol Med; 1987 Feb; 17(1):39-48. PubMed ID: 3575576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication may be required for the development of automatic information processing in schizophrenia.
    Serper MR; Bergman RL; Harvey PD
    Psychiatry Res; 1990 Jun; 32(3):281-8. PubMed ID: 2388967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)].
    Bruck J; Guss H
    Int Pharmacopsychiatry; 1974; 9(3):152-65. PubMed ID: 4154320
    [No Abstract]   [Full Text] [Related]  

  • 30. Basic principles in the use of antipsychotic agents.
    Mason AS
    Hosp Community Psychiatry; 1973 Dec; 24(12):825-9. PubMed ID: 4148176
    [No Abstract]   [Full Text] [Related]  

  • 31. Potentiation of haloperidol by -methyldopa in the treatment of schizophrenic patients.
    Chouinard G; Serrano PM; Tetreault L
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):473-83. PubMed ID: 4198310
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroleptics and the corpus striatum: clinical implications.
    Stimmel GL
    Dis Nerv Syst; 1976 Apr; 37(4):219-24. PubMed ID: 1253676
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)].
    Bourgeois M; Bouey P
    Ann Med Psychol (Paris); 1976 Nov; 2(4):669-708. PubMed ID: 1020864
    [No Abstract]   [Full Text] [Related]  

  • 34. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 35. Importance of dopamine metabolism for clinical effects and side effects of neuroleptics.
    Van Praag HM; Korf J
    Am J Psychiatry; 1976 Oct; 133(10):1171-7. PubMed ID: 970488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the interaction between neuroleptics and antiparkinson drugs.
    Julou L
    Mod Probl Pharmacopsychiatry; 1970; 5():50-4. PubMed ID: 5527168
    [No Abstract]   [Full Text] [Related]  

  • 37. Rapid "digitalization" of decompensated schizophrenic patients with antipsychotic agents.
    Donlon PT; Tupin JP
    Am J Psychiatry; 1974 Mar; 131(3):310-2. PubMed ID: 4812695
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical study of a new agent correcting the syndrome of neuroleptic impregnation in acute psychotic states].
    Vauterin C; Veillon F
    Encephale; 1975; 1(1):61-8. PubMed ID: 1093847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiparkinsonian agents and depot phenothiazine.
    Chien CP; Dimascio A; Cole JO
    Am J Psychiatry; 1974 Jan; 131(1):86-90. PubMed ID: 4808437
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.
    McClelland HA
    Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):401-3. PubMed ID: 9966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.